106 related articles for article (PubMed ID: 83202)
1. The human LT system. IV. Studies on the large MW LT complex class: association of these molecules with specific antigen binding receptor(s) in vitro.
Hiserodt JC; Yamamoto RS; Granger GA
Cell Immunol; 1978 Dec; 41(2):380-96. PubMed ID: 83202
[No Abstract] [Full Text] [Related]
2. Mechanisms of lymphocyte-mediated cytotoxicity. II. biochemical and serologic identification of a precursor lymphotoxin form (pre-LT) produced by MLC-sensitized human T lymphocytes in vitro.
Ware CF; Harris PC; Granger GA
J Immunol; 1981 May; 126(5):1927-33. PubMed ID: 6163823
[No Abstract] [Full Text] [Related]
3. Inhibition of human lymphocyte-mediated mitogen-induced cytotoxicity of murine L-929 cells by heterologous anti-human lymphotoxin antisera in vitro.
Hiserodt JC; Granger GA
J Immunol; 1977 Aug; 119(2):374-80. PubMed ID: 301888
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of lymphocyte-mediated cytotoxicity. I. The effects of anti-human lymphotoxin antisera on the cytolysis of allogeneic B cell lines by MLC-sensitized human lymphocytes in vitro.
Ware CF; Granger GA
J Immunol; 1981 May; 126(5):1919-26. PubMed ID: 6452481
[TBL] [Abstract][Full Text] [Related]
5. The human LT system. V. A comparison of the relative lytic effectiveness of various MW human LT classes on 51Cr-labeled allogeneic target cells in vitro: enhanced lysis by LT complexes associated with Ig-like receptor(s).
Yamamoto RS; Hiserodt JC; Granger GA
Cell Immunol; 1979 Jul; 45(2):261-75. PubMed ID: 157226
[No Abstract] [Full Text] [Related]
6. The human lymphotoxin system.
Hiserodt JC; Granger GA
J Reticuloendothel Soc; 1978 Oct; 24(4):427-38. PubMed ID: 81875
[No Abstract] [Full Text] [Related]
7. Studies of human lymphocyte interactions with emphasis on soluble suppressor activity.
Williams RC; Korsmeyer SJ
Clin Immunol Immunopathol; 1978 Mar; 9(3):335-49. PubMed ID: 146582
[No Abstract] [Full Text] [Related]
8. The human LT system. III. Characterization of a high molecular weight LT class (complex) composed of the various smaller MW LT classes and subclasses in association with Ig-like molecules.
Hiserodt JC; Yamamoto RS; Granger GA
Cell Immunol; 1978 Jul; 38(2):417-33. PubMed ID: 79448
[No Abstract] [Full Text] [Related]
9. The human LT serum. X. The initial form released by T-enriched lymphocytes is 150,000 m.w., associated with small nonlytic components, and can dissociate into the smaller alpha, beta, and gamma m.w. classes.
Harris PC; Yamamoto RS; Crane J; Granger GA
J Immunol; 1981 Jun; 126(6):2165-70. PubMed ID: 6164723
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of lymphocyte-mediated cytotoxicity. III. Characterization of the mechanism of inhibition of the human alloimmune lymphocyte-mediated cytotoxic reaction by polyspecific anti-lymphotoxin sera in vitro.
Ware CF; Granger GA
J Immunol; 1981 May; 126(5):1934-40. PubMed ID: 6971314
[No Abstract] [Full Text] [Related]
11. Identification of membrane-associated lymphotoxin (LT) on mitogen-activated human lymphocytes using heterologous anti-LT antisera in vitro.
Hiserodt JC; Ware CF; Harris PC; Granger GA
Cell Immunol; 1977 Dec; 34(2):326-39. PubMed ID: 303942
[No Abstract] [Full Text] [Related]
12. The LT system in experimental animals. II. Physical and immunologic characteristics of molecules with LT activity rapidly released by murine lymphoid cells activated on lectin-coated allogeneic monolayers in vitro.
Hiserodt JC; Tiangco GJ; Granger GA
J Immunol; 1979 Jul; 123(1):317-24. PubMed ID: 312877
[No Abstract] [Full Text] [Related]
13. The human LT system. XI. Identification of LT and "TNF-like" forms from stimulated natural killers, specific and nonspecific cytotoxic human T cells in vitro.
Yamamoto RS; Ware CF; Granger GA
J Immunol; 1986 Sep; 137(6):1878-84. PubMed ID: 2943806
[TBL] [Abstract][Full Text] [Related]
14. Comparison and yield of antigen- or mitogen-induced human lymphotoxins.
Boulos GN; Rosenau W; Goldberg ML
J Immunol; 1974 Apr; 112(4):1347-53. PubMed ID: 4273626
[No Abstract] [Full Text] [Related]
15. Detection of lymphotoxins in vivo. I. Specific identification of short-lived LT activity in the plasma of various human patients employing rabbit anti-human LT sera in vitro.
Granger GA; Shimizu I; Harris L; Andreson J; Horn P
Clin Immunol Immunopathol; 1978 May; 10(1):104-15. PubMed ID: 350462
[No Abstract] [Full Text] [Related]
16. Isolation and identification of an alpha 2 subclass lymphotoxin (LT) subunit from the high-molecular-weight (complex) human LT class.
Devlin JJ; Klostergaard J; Granger GA
Cell Immunol; 1984 Oct; 88(2):297-308. PubMed ID: 6333278
[TBL] [Abstract][Full Text] [Related]
17. The human LT system. II. Immunological relationships of LT molecules released by mitogen activated human lymphocytes in vitro.
Yamamoto RS; Hiserodt JC; Lewis JE; Carmack CE; Granger GA
Cell Immunol; 1978 Jul; 38(2):403-16. PubMed ID: 79447
[No Abstract] [Full Text] [Related]
18. The LT system in experimental animals. IV. Rapid specific lysis of 51CR-labeled allogeneic target cells by highly unstable high m.w. lymphotoxin-receptor complex(es) released in vitro by activated alloimmune murine T lymphocytes.
Hiserodt JC; Tiangco GJ; Granger GA
J Immunol; 1979 Jul; 123(1):332-41. PubMed ID: 312879
[No Abstract] [Full Text] [Related]
19. Dissociation of lymphocyte activating determinants from recognition sites in mouse MLR.
Abbasi K; Festenstein H; Verbi W; Roitt IM
Nature; 1974 Sep; 251(5472):227-9. PubMed ID: 4138667
[No Abstract] [Full Text] [Related]
20. Inhibition of lymphocyte proliferative responses by anti-HL-A alloantisera.
Brochier J; Roitt IM; Festenstein H
Eur J Immunol; 1974 Nov; 4(11):709-15. PubMed ID: 4279178
[No Abstract] [Full Text] [Related]
[Next] [New Search]
